Metropolitan Life Insurance Company (MetLife)’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,378
Closed -$1.43M 1315
2024
Q1
$1.43M Sell
13,378
-123
-0.9% -$13.1K 0.06% 266
2023
Q4
$1.34M Sell
13,501
-198
-1% -$19.7K 0.06% 272
2023
Q3
$1.41M Sell
13,699
-588
-4% -$60.7K 0.07% 237
2023
Q2
$1.74M Sell
14,287
-490
-3% -$59.5K 0.08% 208
2023
Q1
$2.27M Sell
14,777
-3,557
-19% -$546K 0.12% 154
2022
Q4
$3.29M Sell
18,334
-984
-5% -$177K 0.15% 139
2022
Q3
$2.28M Sell
19,318
-796
-4% -$94.1K 0.11% 181
2022
Q2
$2.87M Sell
20,114
-914
-4% -$131K 0.13% 156
2022
Q1
$3.62M Sell
21,028
-34,053
-62% -$5.87M 0.13% 152
2021
Q4
$14M Sell
55,081
-1,503
-3% -$382K 0.19% 90
2021
Q3
$21.8M Buy
56,584
+33,128
+141% +$12.7M 0.32% 56
2021
Q2
$5.51M Buy
23,456
+2,695
+13% +$633K 0.08% 197
2021
Q1
$2.72M Sell
20,761
-934
-4% -$122K 0.04% 384
2020
Q4
$2.27M Sell
21,695
-423
-2% -$44.2K 0.03% 428
2020
Q3
$1.56M Buy
22,118
+770
+4% +$54.5K 0.03% 511
2020
Q2
$1.37M Buy
21,348
+6,710
+46% +$431K 0.02% 561
2020
Q1
$438K Buy
14,638
+659
+5% +$19.7K 0.01% 1122
2019
Q4
$273K Sell
13,979
-67
-0.5% -$1.31K ﹤0.01% 1707
2019
Q3
$224K Buy
14,046
+12,233
+675% +$195K ﹤0.01% 1801
2019
Q2
$26.5K Sell
1,813
-40
-2% -$586 ﹤0.01% 2573
2019
Q1
$37.7K Buy
+1,853
New +$37.7K ﹤0.01% 2517